Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001562180-22-001075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $30.00 | -1,100 | 30.9K | -3% | -$33.0K |
| D | 2022-02-03 | 2022-02-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $10.80 | +1,100 | 32.0K | +4% | +$11.9K |
| D | 2022-02-03 | 2022-02-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $0.00 | -1,100 | 5,820 | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | S | D | 1,100 | $30.00 | 30,882 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-01 | M | A | 1,100 | $10.80 | 31,982 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-01 | M | D | 1,100 | $0.00 | 5,820 | D | $10.80 · — to 2028-09-27 | 1,100 Common Stock | (F2) 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |